• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

How to Transfer Skincare Complaint History to a New Manufacturing Partner

Switching manufacturers is a formula-and-packaging project, but the part that most often gets lost in the handover is the complaint file. Body care brands that move a body wash, lotion, or body serum to…

Category: Body Care Sourcing Guides • Author: laeyo • Published: 2026-11-17 • Views: 9

Switching manufacturers is a formula-and-packaging project, but the part that most often gets lost in the handover is the complaint file. Body care brands that move a body wash, lotion, or body serum to a new partner without transferring complaint history usually rediscover the same problems 6–12 months later — a pump that leaks at 40°C, a fragrance that smells different after the base changes, a “tingling” sensation that quietly becomes a repeat adverse event. This guide explains what to hand over, how to classify each complaint before you hand it over, and what evidence to demand from the incoming manufacturer so the file stays usable.

Why complaint history is an asset, not paperwork

A complaint log is the only record that connects a specific batch, a specific packaging lot, and a specific consumer experience. When you move production, the new manufacturer inherits your formula — but not your failure memory. That memory is what tells them which parameters are fragile.

  • It sets the specification limits. If 12 complaints traced to viscosity drift above 28,000 cP at 3 months, the new spec sheet should not be written at 30,000 cP.
  • It flags packaging-compatibility risk. Leaks, pump prime failures, label lifting, and fragrance-plastic interaction usually only appear in real packs, not in bench samples.
  • It anchors adverse-event (AE) trending. Without a pre-transfer baseline, you cannot tell whether a post-transfer uptick is the new site, the new batch, or normal seasonality.
  • It supports claims and safety files. Undisclosed complaint patterns can undermine a safety assessment or a claims substantiation file during review.

Define the six data blocks before you talk to anyone

Most brands hand over a spreadsheet of free-text complaints. That is not transferable. Structure the file into six blocks, each with a clear owner, so the incoming manufacturer can actually act on it.

Data block What it contains Why the incoming manufacturer needs it Owner
Complaint register Date, market, channel, SKU, batch/lot, verbatim consumer statement, category code, resolution Baseline rate per 10,000 units so post-transfer trends can be compared Brand (quality/CS)
AE subset Any report involving a safety signal: irritation, sensitization, infection suspicion, ocular or mucosal exposure Must be treated as a safety signal until evidence shows otherwise — not as an efficacy complaint Brand + manufacturer (joint review)
Root-cause and CAPA log What was investigated, what was concluded, what corrective action closed it, effectiveness check result Prevents re-opening closed issues and stops the new site repeating a known failure Previous manufacturer
OOS/OOT and deviation history Out-of-specification results, out-of-trend results, batch deviations and dispositions Tells the new site which tests are borderline and where the process window is narrow Previous manufacturer
Packaging complaint file Leak, crack, pump/valve failure, label adhesion, corrosion, fragrance–plastic interaction Packaging is usually the largest single complaint category and is often changed at the same time Brand + packaging supplier
Stability and micro history Protocols, results at each checkpoint, any reformulation triggered by a stability failure Defines what must be re-run, and which preservative or viscosity assumptions are unproven Previous manufacturer / lab

Classify every complaint before you transfer it

The most common transfer error is mis-coding a safety signal as an efficacy complaint. Once a complaint is labelled “product didn’t work,” it stops triggering investigation, and the incoming manufacturer never learns about it.

Take a typical body care statement: “It made my skin itch more.” This sits on the adverse-event and efficacy boundary. Treat it as a safety signal until you can demonstrate it is not product-related. Do not downgrade it to “ineffective” or “consumer preference.”

  • Ask discriminating questions, not open ones. Was it itching, stinging, burning, or a visible rash? Did it start on first use or after several days? Which body area? Was the batch number recorded? Did the consumer see a clinician, and was a diagnosis given? Were other products introduced in the same period?
  • Separate defect from perception. A pH shift outside specification, a preservative challenge failure, or microbial contamination is a product defect. “Feels less rich than before” is a sensory or expectation issue that belongs in marketing and reformulation, not in the AE file.
  • Look for clustering. Two complaints on one batch is a data point; eight on one batch in three weeks is a signal that requires a batch record review and a trend decision.
  • Document the boundary decision. Record why a case was classified as AE or efficacy, and who approved that classification. This is the record an auditor or a safety assessor will ask for.

Route each complaint into one of the five quality chains

Every complaint should map to a quality process, otherwise it dies in a customer service inbox. Use the same five-chain logic in the transfer meeting so the new manufacturer knows what “closed” means.

  • Complaint: Is the market feedback valid, how large is the impact, and how will it be resolved? Owner: brand quality with manufacturer support.
  • NCR (Non-Conformance Report): How was the affected material or finished batch dispositioned — released, reworked, rejected, destroyed? This tells the new site what your acceptance bar actually is.
  • OOS/OOT: Was the result real, and why did it move? Attach the investigation, not just the failing value.
  • Deviation: Did an execution deviation (weighing, hold time, temperature, filling) affect quality, and was the batch still released with justification?
  • CAPA: What prevents recurrence, and was effectiveness verified? An open CAPA must be explicitly accepted or closed by the incoming manufacturer in writing.

Build the transfer pack: what to hand over

  • Complaint register covering at least 24 months, exported as a structured file, plus the category definitions used to code it.
  • AE subset with classification rationale and any medical follow-up records that may be shared.
  • Closed and open CAPA list, with effectiveness-check status for each.
  • OOS/OOT and deviation summaries tied to batch numbers.
  • Stability protocol and full result tables, including any failed checkpoint and the resulting formula revision.
  • Micro test history and preservative efficacy results.
  • Packaging complaint summary with photos and the packaging supplier’s own investigation responses.
  • Batch records or batch record summaries for the batches that generated complaints (subject to confidentiality terms).
  • A written list of “fragile parameters” — the three to five specification points most likely to drift.

Change control: what actually changes when the manufacturer changes

Buyers often assume that keeping the same INCI list means no re-assessment is needed. It does not. A new manufacturing site can change the raw material supplier, the grade, the processing temperature, the mixing shear, the fill weight, and the packaging converter — all without changing the INCI declaration on the label.

The same principle applies to a single ingredient change. If a fragrance supplier changes, the new fragrance may differ in composition, purity, and impurities, which changes consumer exposure. That triggers a full toxicology and safety information review, an assessment of whether finished-product tolerance testing is required, updates to the product safety report and to market-specific filing documentation, a review of allergen-related label warnings, and post-launch monitoring of AE trends linked to the new batch.

  • Do not accept “same INCI, so it’s the same.” Request a COA comparison, a small-scale trial, key stability data, viscosity/pH/appearance, sensory and application performance, and — where relevant — preservative efficacy and claim support.
  • Test the real product combination. Where feasible, test the final pack, the dose, and the application method together rather than the formula alone. This is closer to real use and is a stronger defence when complaints arrive.
  • Version the formula properly. A unique formula ID, the reason for change, the old and new INCI and supplier, an impact assessment across sensory, stability, efficacy, preservation, regulatory, packaging, and cost, the defined re-test scope, and named approvals.

Set a 90-day post-transfer monitoring window

  • Compare complaint rate per 10,000 units against the transferred baseline, by category, not in aggregate.
  • Tag every complaint to the first production batch so batch-level clustering is visible immediately.
  • Hold a joint review at day 30 (early signals), day 60 (trend confirmation), and day 90 (close or escalate).
  • Pre-agree the escalation trigger in writing — for example, an AE rate above baseline, or any confirmed packaging failure mode recurring twice.
  • Confirm who owns the complaint record going forward, and how the brand regains access to it if the relationship ends.

Common transfer mistakes

  • Handing over a free-text complaint export with no category codes, so nothing can be trended.
  • Closing open CAPAs administratively instead of verifying effectiveness.
  • Treating irritation reports as “sensitivity” without investigating the batch.
  • Transferring the formula but not the packaging complaint file.
  • Assuming a new site’s GMP certificate alone proves the process window matches yours.
  • Skipping a re-test because “nothing changed on the label.”
  • No agreed definition of what counts as a complaint on the new site’s side.

FAQ

Do we have to hand over the full complaint register, including consumer names?

No. Transfer the structured, de-identified data — date, market, SKU, batch, coded complaint category, verbatim statement, and resolution. Personal data should be removed or minimised unless there is a specific safety reason and a lawful basis to share it. The technical value is in the pattern, not the identity.

What if the previous manufacturer refuses to share batch records?

You may not get full batch records, but you should still obtain the OOS/OOT summary, deviation summary, stability results, and CAPA status. If the outgoing manufacturer will not provide them, document the gap in writing and ask the incoming manufacturer to re-establish the missing baseline through its own stability and micro testing. An undocumented gap is a bigger risk than a known one.

Is a complaint about “less lather” or “feels thinner” a quality issue?

Usually not — it is a sensory or expectation issue unless it correlates with a measurable specification shift. Check viscosity, pH, solids content, and density against spec first. If the batch is in spec, route it to marketing and reformulation; if it is out of trend, open an OOT investigation.

How long should the historical data cover?

Twenty-four months is a practical minimum for a body care SKU with seasonal variation, and it should include at least one full summer and winter cycle. If the product has been on market under three years, transfer the entire history.

Who signs off that the transfer is complete?

Quality should sign off on documentation completeness, regulatory on safety file and label updates, and the commercial owner on the monitoring plan. A transfer is not complete until the incoming manufacturer has confirmed in writing which historical CAPAs it accepts as closed and which it is re-opening.

If you are planning a manufacturer transfer and want the complaint file reviewed alongside the formula and packaging, Request a Quote and include your target market, SKU list, packaging direction, and current complaint categories.

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).